Bucladesine
From Self-sufficiency
Revision as of 14:24, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))
| File:Bucladesine.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
sodium (3aR,4R,6R,6aR)-4-(6-butanamido-9H-purin-9-yl)-6-[(butanoyloxy)methyl]-2-oxo-tetrahydro-2H-1,3,5,2λ5-furo[3,4-d][1,3,2]dioxaphosphol-2-olate | |
| Identifiers | |
| CAS Number | 362-74-3 |
| ATC code | C01CE04 (WHO) |
| PubChem | CID 28177 |
| Synonyms |
• Dibutyryl cyclic adenosine monophosphate • (N6,2'-O-dibutyryl-adenosine-3',5'-mono-phosphate • Dibutyryl cAMP • DcAMP • DBcAMP |
| Chemical data | |
| Formula | C18H23N5NaO8P |
| Molar mass | 491.368 g/mol[[Script error: No such module "String".]] |
Bucladesine is a cyclic nucleotide derivative which mimics the action of endogenous cAMP and is a phosphodiesterase inhibitor.
Bucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations.
External links
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Nucleotides
- Amides
- PDE3 inhibitors
- Cardiovascular system drug stubs
